癌症检测中的尿路生物标志物:探索,进步,挑战和未来方向
Weixuan Pan1, Jiali Xing1, Xiaokun Chen1
1Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
International journal of surgery (London, England)
|November 11, 2025
概括
尿液生物标志物显示出对非侵入性癌症检测的前景,特别是对于泌尿系统恶性瘤. 多种病理学方面的进步提高了诊断准确性和疾病监测,有助于临床整合.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 在瘤学瘤学.
- 生物标志物发现发现
背景情况:
- 尿液是生理和病理状态生物标志物的丰富来源.
- 非侵入性尿路生物标志物对于检测尿道癌症如膀,前列腺和宫恶性瘤是有价值的.
- 多omics技术 (基因组学,蛋白质组学,代谢组学) 提高分析灵敏度和特异性.
研究的目的:
- 审查癌症检测尿路生物标志物发现的最新进展.
- 检查这些生物标志物在各种癌症中的临床应用.
- 批判性地评估尿路生物标志物的诊断潜力,局限性和挑战.
主要方法:
- 对尿路生物标志物的最新文献进行系统审查.
- 分析用于生物标志物识别的多omics数据.
- 对诊断准确性和疾病监测的临床研究的评估.
主要成果:
- 尿路生物标志物显示出早期癌症检测和监测的巨大潜力.
- 多omics方法提高了诊断测试的灵敏度和特异性.
- 在将这些生物标志物纳入临床实践方面取得了进展.
结论:
- 尿路生物标志物为癌症管理提供了一个有希望的非侵入性策略.
- 需要进一步优化和验证才能克服当前的局限性.
- 尿路生物标志物策略的更广泛的临床整合对于改善癌症护理至关重要.
相关概念视频
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
239
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
239
Urine Studies I: Urinalysis
1.1K
Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
1.1K


